BetterLife Pharma Inc. (CSE:BETR)
Canada
· Delayed Price · Currency is CAD 0.1000
+0.0050 (5.26%)
Jun 27, 2025, 9:43 AM EDT
BetterLife Pharma Balance Sheet
Financials in millions CAD. Fiscal year is February - January.
Millions CAD. Fiscal year is Feb - Jan.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 0.01 | 0.04 | 0.01 | 0.17 | 0.15 | Upgrade
|
Cash & Short-Term Investments | 0.01 | 0.04 | 0.01 | 0.17 | 0.15 | Upgrade
|
Cash Growth | -78.12% | 350.03% | -95.21% | 12.14% | -94.23% | Upgrade
|
Other Receivables | 0.01 | 0.04 | 0.02 | 0.32 | 0.52 | Upgrade
|
Receivables | 0.01 | 0.04 | 0.02 | 0.32 | 0.52 | Upgrade
|
Prepaid Expenses | 0.21 | 0.25 | 0.05 | 0.64 | 0.65 | Upgrade
|
Total Current Assets | 0.22 | 0.32 | 0.07 | 1.14 | 1.33 | Upgrade
|
Property, Plant & Equipment | - | - | - | 0.02 | 0.04 | Upgrade
|
Total Assets | 0.22 | 0.32 | 0.07 | 1.16 | 1.37 | Upgrade
|
Accounts Payable | 4.5 | 4.44 | 4.9 | 3.34 | 4.5 | Upgrade
|
Accrued Expenses | 1.07 | 1.6 | 1.39 | 0.14 | 0.66 | Upgrade
|
Short-Term Debt | 0.46 | 0.23 | 0.19 | 0.28 | 0.5 | Upgrade
|
Current Portion of Long-Term Debt | 0.82 | 0.25 | - | - | - | Upgrade
|
Current Income Taxes Payable | - | - | - | 0.16 | - | Upgrade
|
Other Current Liabilities | 0.7 | 0.83 | 0.67 | 0.22 | 0.18 | Upgrade
|
Total Current Liabilities | 7.54 | 7.35 | 7.15 | 4.14 | 5.85 | Upgrade
|
Long-Term Debt | 0.05 | 0.08 | - | 0.03 | - | Upgrade
|
Other Long-Term Liabilities | - | 0.59 | 0.46 | 0.86 | 0.13 | Upgrade
|
Total Liabilities | 7.59 | 8.02 | 7.61 | 5.04 | 5.98 | Upgrade
|
Common Stock | 79.97 | 78.46 | 76.57 | 75.38 | 63.67 | Upgrade
|
Retained Earnings | -118.6 | -115.08 | -112.19 | -103.17 | -91.01 | Upgrade
|
Comprehensive Income & Other | 27.95 | 25.81 | 24.89 | 23.91 | 22.73 | Upgrade
|
Total Common Equity | -10.68 | -10.81 | -10.73 | -3.88 | -4.61 | Upgrade
|
Minority Interest | 3.32 | 3.11 | 3.19 | - | - | Upgrade
|
Shareholders' Equity | -7.36 | -7.7 | -7.53 | -3.88 | -4.61 | Upgrade
|
Total Liabilities & Equity | 0.22 | 0.32 | 0.07 | 1.16 | 1.37 | Upgrade
|
Total Debt | 1.33 | 0.56 | 0.19 | 0.31 | 0.5 | Upgrade
|
Net Cash (Debt) | -1.32 | -0.52 | -0.18 | -0.14 | -0.35 | Upgrade
|
Net Cash Per Share | -0.01 | -0.00 | -0.00 | -0.00 | -0.01 | Upgrade
|
Filing Date Shares Outstanding | 145.49 | 117.08 | 108.68 | 84.4 | 84.32 | Upgrade
|
Total Common Shares Outstanding | 129.57 | 115.83 | 90.1 | 85.24 | 51.45 | Upgrade
|
Working Capital | -7.31 | -7.02 | -7.07 | -3 | -4.52 | Upgrade
|
Book Value Per Share | -0.08 | -0.09 | -0.12 | -0.05 | -0.09 | Upgrade
|
Tangible Book Value | -10.68 | -10.81 | -10.73 | -3.88 | -4.61 | Upgrade
|
Tangible Book Value Per Share | -0.08 | -0.09 | -0.12 | -0.05 | -0.09 | Upgrade
|
Machinery | - | - | - | 0.04 | 0.04 | Upgrade
|
Updated Dec 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.